| Product Code: ETC10708681 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Opioid Induced Constipation Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Opioid Induced Constipation Market Revenues & Volume, 2021 & 2031F |
3.3 France Opioid Induced Constipation Market - Industry Life Cycle |
3.4 France Opioid Induced Constipation Market - Porter's Five Forces |
3.5 France Opioid Induced Constipation Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 France Opioid Induced Constipation Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 France Opioid Induced Constipation Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.8 France Opioid Induced Constipation Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 France Opioid Induced Constipation Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions leading to higher opioid usage |
4.2.2 Growing aging population in France with higher likelihood of experiencing constipation |
4.2.3 Rising awareness among healthcare professionals about opioid-induced constipation and the need for effective management |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines surrounding opioid prescribing and usage |
4.3.2 Potential side effects and risks associated with opioid-induced constipation treatments |
4.3.3 Competition from alternative treatment options for constipation |
5 France Opioid Induced Constipation Market Trends |
6 France Opioid Induced Constipation Market, By Types |
6.1 France Opioid Induced Constipation Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 France Opioid Induced Constipation Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 France Opioid Induced Constipation Market Revenues & Volume, By Peripherally Acting Mu-Opioid Receptor Antagonists (PAMORAs), 2021 - 2031F |
6.1.4 France Opioid Induced Constipation Market Revenues & Volume, By Laxatives, 2021 - 2031F |
6.1.5 France Opioid Induced Constipation Market Revenues & Volume, By Prokinetic Agents, 2021 - 2031F |
6.1.6 France Opioid Induced Constipation Market Revenues & Volume, By Natural Remedies, 2021 - 2031F |
6.2 France Opioid Induced Constipation Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 France Opioid Induced Constipation Market Revenues & Volume, By Receptor Blockade, 2021 - 2031F |
6.2.3 France Opioid Induced Constipation Market Revenues & Volume, By Osmotic, 2021 - 2031F |
6.2.4 France Opioid Induced Constipation Market Revenues & Volume, By Gut Motility Enhancement, 2021 - 2031F |
6.2.5 France Opioid Induced Constipation Market Revenues & Volume, By Fiber Supplements, 2021 - 2031F |
6.3 France Opioid Induced Constipation Market, By Dosage Form |
6.3.1 Overview and Analysis |
6.3.2 France Opioid Induced Constipation Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.3.3 France Opioid Induced Constipation Market Revenues & Volume, By Oral Solutions, 2021 - 2031F |
6.3.4 France Opioid Induced Constipation Market Revenues & Volume, By Injections, 2021 - 2031F |
6.3.5 France Opioid Induced Constipation Market Revenues & Volume, By Powders, 2021 - 2031F |
6.4 France Opioid Induced Constipation Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 France Opioid Induced Constipation Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 France Opioid Induced Constipation Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 France Opioid Induced Constipation Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 France Opioid Induced Constipation Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
7 France Opioid Induced Constipation Market Import-Export Trade Statistics |
7.1 France Opioid Induced Constipation Market Export to Major Countries |
7.2 France Opioid Induced Constipation Market Imports from Major Countries |
8 France Opioid Induced Constipation Market Key Performance Indicators |
8.1 Number of healthcare professionals trained in opioid-induced constipation management |
8.2 Patient adherence rates to prescribed opioid-induced constipation treatments |
8.3 Frequency of opioid-induced constipation cases reported in healthcare facilities |
9 France Opioid Induced Constipation Market - Opportunity Assessment |
9.1 France Opioid Induced Constipation Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 France Opioid Induced Constipation Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 France Opioid Induced Constipation Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.4 France Opioid Induced Constipation Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 France Opioid Induced Constipation Market - Competitive Landscape |
10.1 France Opioid Induced Constipation Market Revenue Share, By Companies, 2024 |
10.2 France Opioid Induced Constipation Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here